Arno Therapeutics, Inc.

OTCPK:ARNI Stock Report

Market Cap: US$4.9k

Arno Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure14.2yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Arno Therapeutics has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Jay Moorin
Independent Director8.8yrsno datano data
Tomer Kariv
Independent Director14.2yrsUS$54.00kno data
William Hamilton
Independent Director16.1yrsUS$62.84kno data
Stuart Holden
Chair of Scientific Advisory Board8.8yrsno datano data
Steven Rubin
Board Observer11yrsno datano data
Arie Belldegrun
Chairman16.7yrsUS$150.00kno data
Steven Ruchefsky
Independent Director14.2yrsUS$77.19kno data
Yacov Reizman
Independent Director14.2yrsUS$54.50kno data

14.2yrs

Average Tenure

73yo

Average Age

Experienced Board: ARNI's board of directors are seasoned and experienced ( 14.2 years average tenure).